New developments and directions in the clinical application of the echinocandins
CC Chang, MA Slavin, SC-A Chen
Archives of Toxicology | SPRINGER HEIDELBERG | Published : 2017
All authors declared that there is no conflict of interest. SC-AC and MAS are members of the Antifungal Advisory Boards of Gilead Sciences Inc., Merck, and Pfizer, Australia, and have received untied investigator-initiated grants from Pfizer Australia, Gilead Sciences and Merck.